63 related articles for article (PubMed ID: 5116056)
1. Myocardial effects of indoramin hydrochloride, a new hypotensive agent.
Coltart DJ; Meldrum SJ; Royds RB
Br J Pharmacol; 1971 Aug; 42(4):664P-665P. PubMed ID: 5116056
[No Abstract] [Full Text] [Related]
2. Human pharmacology of indoramin.
Coltart DJ; Lockhart JD; Royds RB; Turner P
Br J Pharmacol; 1971 Oct; 43(2):467P-468P. PubMed ID: 4400576
[No Abstract] [Full Text] [Related]
3. Proceedings: Haemodynamic effects of indoramin: a non-invasive technique for the cardiovascular evaluation of drugs.
Coltart DJ; Royds RB
Br J Pharmacol; 1972 Feb; 44(2):387P-388P. PubMed ID: 4668640
[No Abstract] [Full Text] [Related]
4. Proceedings: Initial clinical experience with indoramin, a new antihypertensive agent.
Royds RB
Br J Pharmacol; 1972 Feb; 44(2):379P-380P. PubMed ID: 4668635
[No Abstract] [Full Text] [Related]
5. New indolic hypotensive agents.
Dubey M; Verma VK; Shanker K; Sinha JN; Bhargava KP; Kishor K
Pharmazie; 1978 Oct; 33(10):640-1. PubMed ID: 724743
[TBL] [Abstract][Full Text] [Related]
6. Pharmacologic studies of indoramin in man.
Royds RB; Coltart DJ; Lockhart JD
Clin Pharmacol Ther; 1972; 13(3):380-92. PubMed ID: 4402080
[No Abstract] [Full Text] [Related]
7. The relationship of intracellular depolarization rates and contractility in the dog ventricle in situ: effects of positive and negative inotropic agents.
Pruett JK; Woods EF
J Pharmacol Exp Ther; 1967 Jul; 157(1):1-7. PubMed ID: 6029486
[No Abstract] [Full Text] [Related]
8. Benzamidopiperidines. 2. Heterocyclic compounds related to indoramin.
Archibald JL; Benke GA
J Med Chem; 1974 Jul; 17(7):736-9. PubMed ID: 4151968
[No Abstract] [Full Text] [Related]
9. Studies on the hypotensive and bradycardic effects of 1-piperidinylmethyl-2-naphthol hydrochloride.
Shen AY; Huang MH; Wang TS
Res Commun Mol Pathol Pharmacol; 1997 Nov; 98(2):209-20. PubMed ID: 9467829
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic properties of minoxidil: a new hypotensive agent.
DuCharme DW; Freyburger WA; Graham BE; Carlson RG
J Pharmacol Exp Ther; 1973 Mar; 184(3):662-70. PubMed ID: 4631469
[No Abstract] [Full Text] [Related]
11. [Investigation of pharmacologic agents with prolonged hypotensive action].
Vinogradova EV; Grinev AN; Danusevich IK; Dzik MF; Dubovik BV; Zakharevskiĭ AS; Il'iuchenok TIu; Kost AN; Martinovich GI; Miklevich AV; Pil'tienko LF; Rachkovskaia IV; Reut NA; Talapin VI; Tamarina NZ; Terent'ev AP; Shadurskiĭ KS
Vestn Akad Med Nauk SSSR; 1963; 18(1):69-86. PubMed ID: 5889339
[No Abstract] [Full Text] [Related]
12. Synthesis and hypotensive activity of benzamidopiperidylethylindoles.
Archibald JL; Alps BJ; Cavalla JF; Jackson JL
J Med Chem; 1971 Nov; 14(11):1054-9. PubMed ID: 5115203
[No Abstract] [Full Text] [Related]
13. Antihypertensive properties of a new long-acting angiotensin converting enzyme inhibitor in renin-dependent and independent hypertensive models.
Nagata S; Takeyama K; Fukuya F; Nagai R; Hosoki K; Nishimura K; Deguchi T; Karasawa T
Arzneimittelforschung; 1995 Aug; 45(8):853-8. PubMed ID: 7575746
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular effects of (2RS,3SR)- 2-aminomethyl-2,3,7,8-tetrahydro-2,3,5,8,8-pentamethyl-6H-furo- [2,3-e]indol-7-one hydrochloride (UK-1745), a novel cardiotonic agent with vasodilatory and antiarrhythmic properties.
Uchida Y; Kawada M; Sawanobori K; Sonoki H; Inoue K; Mizuno K; Itou T; Tabunoki Y; Tsukamoto M; Ohashi Y; Kyotani Y; Shimizu N; Fujii M; Nakamura M
Arzneimittelforschung; 1998 Mar; 48(3):219-31. PubMed ID: 9553677
[TBL] [Abstract][Full Text] [Related]
15. New optimized piperamide analogues with potent in vivo hypotensive properties.
de Mattos Duarte C; Verli H; de Araújo-Júnior JX; de Medeiros IA; Barreiro EJ; Fraga CA
Eur J Pharm Sci; 2004 Dec; 23(4-5):363-9. PubMed ID: 15567289
[TBL] [Abstract][Full Text] [Related]
16. The hypotensive effect of trimazosin is not caused solely by alpha 1-adrenoceptor blockade.
Constantine JW; Lebel W; Weeks R
J Cardiovasc Pharmacol; 1984; 6(1):142-50. PubMed ID: 6199597
[TBL] [Abstract][Full Text] [Related]
17. Cellular electrophysiological effect of terikalant in the dog heart.
Biliczki P; Acsai K; Virág L; Tálosi L; Jost N; Biliczki A; Papp JG; Varró A
Eur J Pharmacol; 2005 Mar; 510(3):161-6. PubMed ID: 15763239
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiologic effects of 3-(p-chlorophenyl)-(2-imadazolin-2-yl-methyl)-1,2,3,4-tetrahydro-1-benzepine hydrochloride (SU-13197), a new antiarrhythmic agent.
Watanabe Y; Dreifus LS
J Pharmacol Exp Ther; 1968 Jan; 159(1):146-52. PubMed ID: 5643942
[No Abstract] [Full Text] [Related]
19. Effects of flecainide on contractile force and electrophysiological parameters in cardiac muscle.
Schulze JJ; Knops J
Arzneimittelforschung; 1982; 32(9):1025-9. PubMed ID: 6890819
[TBL] [Abstract][Full Text] [Related]
20. General pharmacologic actions of the antihypertensive agent 2,6-dichlorobenzylidene aminoguanidine acetate (WY-8678).
Baum T; Shropshire AT; Rowles G; Van Pelt R; Fernandez SP; Eckfeld DK; Gluckman MI
J Pharmacol Exp Ther; 1970 Feb; 171(2):276-87. PubMed ID: 5466490
[No Abstract] [Full Text] [Related]
[Next] [New Search]
